

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 4.85343338 |
| 2 | positive thymic T cell selection (GO:0045059) | 4.75407271 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.72397216 |
| 4 | B cell receptor signaling pathway (GO:0050853) | 4.54365697 |
| 5 | mannose metabolic process (GO:0006013) | 4.18009570 |
| 6 | detection of other organism (GO:0098543) | 3.82633150 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77865902 |
| 8 | detection of bacterium (GO:0016045) | 3.77564947 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64614479 |
| 10 | positive regulation of B cell differentiation (GO:0045579) | 3.63323971 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 3.62494512 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.61058458 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.58611572 |
| 14 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.46426849 |
| 15 | positive T cell selection (GO:0043368) | 3.45161436 |
| 16 | regulation of leukocyte degranulation (GO:0043300) | 3.44116587 |
| 17 | regulation of mast cell degranulation (GO:0043304) | 3.36213162 |
| 18 | negative thymic T cell selection (GO:0045060) | 3.34579199 |
| 19 | regulation of B cell differentiation (GO:0045577) | 3.33238125 |
| 20 | translesion synthesis (GO:0019985) | 3.32921733 |
| 21 | cellular extravasation (GO:0045123) | 3.31604725 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.30810163 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.30810163 |
| 24 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.29010253 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 3.28701691 |
| 26 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.28399873 |
| 27 | germinal center formation (GO:0002467) | 3.24955207 |
| 28 | pre-miRNA processing (GO:0031054) | 3.24450287 |
| 29 | negative T cell selection (GO:0043383) | 3.18799402 |
| 30 | regulation of chromatin binding (GO:0035561) | 3.13385176 |
| 31 | thymic T cell selection (GO:0045061) | 3.08130544 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.08010089 |
| 33 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.06321315 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.05423154 |
| 35 | DNA unwinding involved in DNA replication (GO:0006268) | 3.04265106 |
| 36 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.02580609 |
| 37 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.02580609 |
| 38 | modulation by symbiont of host immune response (GO:0052553) | 3.02580609 |
| 39 | positive regulation by symbiont of host defense response (GO:0052509) | 3.02580609 |
| 40 | modulation by symbiont of host defense response (GO:0052031) | 3.02580609 |
| 41 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.02580609 |
| 42 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.01109089 |
| 43 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.99122277 |
| 44 | positive regulation of type 2 immune response (GO:0002830) | 2.98645522 |
| 45 | leukocyte aggregation (GO:0070486) | 2.97971915 |
| 46 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.97264107 |
| 47 | B cell homeostasis (GO:0001782) | 2.96995290 |
| 48 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.95189074 |
| 49 | negative regulation of histone methylation (GO:0031061) | 2.93067839 |
| 50 | response to laminar fluid shear stress (GO:0034616) | 2.91555023 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.87694461 |
| 52 | macrophage activation involved in immune response (GO:0002281) | 2.87200672 |
| 53 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.86435809 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.84484368 |
| 55 | detection of biotic stimulus (GO:0009595) | 2.84201976 |
| 56 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.82917350 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.82191301 |
| 58 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78912849 |
| 59 | response to host immune response (GO:0052572) | 2.78912849 |
| 60 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77936935 |
| 61 | response to host (GO:0075136) | 2.77936935 |
| 62 | response to host defenses (GO:0052200) | 2.77936935 |
| 63 | regulation of superoxide anion generation (GO:0032928) | 2.77105628 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76616401 |
| 65 | regulation of regulated secretory pathway (GO:1903305) | 2.75946965 |
| 66 | regulation of type 2 immune response (GO:0002828) | 2.75884395 |
| 67 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.75623140 |
| 68 | tolerance induction (GO:0002507) | 2.75214992 |
| 69 | negative regulation of RNA splicing (GO:0033119) | 2.74700919 |
| 70 | regulation of tolerance induction (GO:0002643) | 2.72887560 |
| 71 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.71685355 |
| 72 | negative regulation of granulocyte differentiation (GO:0030853) | 2.71253553 |
| 73 | negative regulation of B cell proliferation (GO:0030889) | 2.71121071 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 2.71086638 |
| 75 | T cell selection (GO:0045058) | 2.70948886 |
| 76 | histone H3-K4 methylation (GO:0051568) | 2.70654976 |
| 77 | determination of adult lifespan (GO:0008340) | 2.69972354 |
| 78 | pinocytosis (GO:0006907) | 2.67478111 |
| 79 | detection of molecule of bacterial origin (GO:0032490) | 2.67468813 |
| 80 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.66960547 |
| 81 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.65373394 |
| 82 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.65373394 |
| 83 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65036467 |
| 84 | macrophage activation (GO:0042116) | 2.63326286 |
| 85 | protein-DNA complex disassembly (GO:0032986) | 2.62723775 |
| 86 | nucleosome disassembly (GO:0006337) | 2.62723775 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 2.61590604 |
| 88 | protein localization to endosome (GO:0036010) | 2.61545956 |
| 89 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.61177463 |
| 90 | negative regulation of type 2 immune response (GO:0002829) | 2.60980347 |
| 91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.60721690 |
| 92 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.59196282 |
| 93 | type I interferon signaling pathway (GO:0060337) | 2.58520534 |
| 94 | cellular response to type I interferon (GO:0071357) | 2.58520534 |
| 95 | response to type I interferon (GO:0034340) | 2.57618889 |
| 96 | histone H3-K36 demethylation (GO:0070544) | 2.57272787 |
| 97 | barbed-end actin filament capping (GO:0051016) | 2.56675560 |
| 98 | modulation by virus of host process (GO:0019054) | 2.56494672 |
| 99 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.55651302 |
| 100 | neutrophil activation (GO:0042119) | 2.55427442 |
| 101 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.55101272 |
| 102 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.54038542 |
| 103 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53134390 |
| 104 | regulation of histone H3-K4 methylation (GO:0051569) | 2.51353040 |
| 105 | histone H3-K4 trimethylation (GO:0080182) | 2.50972978 |
| 106 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50920276 |
| 107 | negative regulation of mRNA processing (GO:0050686) | 2.50899586 |
| 108 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.48918875 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.48641635 |
| 110 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.48082417 |
| 111 | histone H2A acetylation (GO:0043968) | 2.46271285 |
| 112 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.45948031 |
| 113 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.45810206 |
| 114 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.45702497 |
| 115 | granulocyte activation (GO:0036230) | 2.44902859 |
| 116 | amyloid precursor protein catabolic process (GO:0042987) | 2.43404197 |
| 117 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.43126649 |
| 118 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.43126649 |
| 119 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.43126649 |
| 120 | dosage compensation (GO:0007549) | 2.42892470 |
| 121 | B cell proliferation (GO:0042100) | 2.42839175 |
| 122 | regulation of monocyte differentiation (GO:0045655) | 2.42140244 |
| 123 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.40904996 |
| 124 | positive regulation of RNA splicing (GO:0033120) | 2.40386080 |
| 125 | positive regulation of mast cell activation (GO:0033005) | 2.40053384 |
| 126 | response to protozoan (GO:0001562) | 2.39715308 |
| 127 | negative regulation of interleukin-8 production (GO:0032717) | 2.39168440 |
| 128 | defense response to protozoan (GO:0042832) | 2.39090834 |
| 129 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.38958861 |
| 130 | stress fiber assembly (GO:0043149) | 2.38438668 |
| 131 | regulation of histone methylation (GO:0031060) | 2.37123408 |
| 132 | chromatin silencing (GO:0006342) | 2.33878552 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.33396698 |
| 134 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.33374618 |
| 135 | negative regulation of mRNA metabolic process (GO:1903312) | 2.33359037 |
| 136 | positive regulation of Rap GTPase activity (GO:0032854) | 2.32762198 |
| 137 | mast cell activation (GO:0045576) | 2.32758455 |
| 138 | lymphocyte homeostasis (GO:0002260) | 2.32446266 |
| 139 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.30369462 |
| 140 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29711216 |
| 141 | mRNA splice site selection (GO:0006376) | 2.29623110 |
| 142 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.29483199 |
| 143 | regulation of ARF GTPase activity (GO:0032312) | 2.28761429 |
| 144 | T cell homeostasis (GO:0043029) | 2.26023426 |
| 145 | negative regulation of interleukin-6 production (GO:0032715) | 2.25754085 |
| 146 | immunoglobulin mediated immune response (GO:0016064) | 2.23939831 |
| 147 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.23657435 |
| 148 | regulation of histone H3-K9 methylation (GO:0051570) | 2.23442972 |
| 149 | respiratory burst (GO:0045730) | 2.23148170 |
| 150 | negative regulation of gene silencing (GO:0060969) | 2.22429601 |
| 151 | mature B cell differentiation (GO:0002335) | 2.22366316 |
| 152 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.21439354 |
| 153 | megakaryocyte development (GO:0035855) | 2.20542242 |
| 154 | negative regulation of chromatin modification (GO:1903309) | 2.18593364 |
| 155 | positive regulation of leukocyte degranulation (GO:0043302) | 2.18304273 |
| 156 | positive regulation of isotype switching (GO:0045830) | 2.18103905 |
| 157 | regulation of chromatin silencing (GO:0031935) | 2.16627970 |
| 158 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.16351288 |
| 159 | positive regulation of histone deacetylation (GO:0031065) | 2.15449615 |
| 160 | mononuclear cell proliferation (GO:0032943) | 2.14205130 |
| 161 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.13587039 |
| 162 | positive regulation of mast cell degranulation (GO:0043306) | 2.13587039 |
| 163 | lymphocyte proliferation (GO:0046651) | 2.12875135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.02852711 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 3.88524463 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.36357613 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.34967310 |
| 5 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.30267934 |
| 6 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.87018616 |
| 7 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.81136403 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.76873641 |
| 9 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.61010599 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.58557388 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58228957 |
| 12 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53593801 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48997358 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.44145382 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.33958504 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.28725968 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.22435006 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.19254100 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.12871945 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.07171430 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.05210627 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.02013174 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.01257283 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.99572628 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98658869 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98631775 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.97737794 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.96805271 |
| 29 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.93259377 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.88363592 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88084545 |
| 32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.86648802 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86525306 |
| 34 | MYB_26560356_Chip-Seq_TH2_Human | 1.86080486 |
| 35 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85223858 |
| 36 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.83305841 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82901944 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.78963036 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.78760975 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.78495317 |
| 41 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76510844 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.75335116 |
| 43 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71397535 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.67615021 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64025585 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62570402 |
| 47 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62438445 |
| 48 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.59910216 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56712283 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.56513046 |
| 51 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.54737598 |
| 52 | MAF_26560356_Chip-Seq_TH2_Human | 1.51517800 |
| 53 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50758973 |
| 54 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50057727 |
| 55 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.48338850 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47314653 |
| 57 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46283064 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.45238442 |
| 59 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.43579536 |
| 60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43174960 |
| 61 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41416493 |
| 62 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40288409 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.40274312 |
| 64 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39741026 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39697428 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39187627 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39045866 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38912044 |
| 69 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.34902688 |
| 70 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.34649204 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33244310 |
| 72 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32849011 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32225224 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31722926 |
| 75 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31412051 |
| 76 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30382413 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28624548 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28471237 |
| 79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27330272 |
| 80 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27133930 |
| 81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.24500850 |
| 82 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.23373112 |
| 83 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23296148 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23126670 |
| 85 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21826553 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21374841 |
| 87 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.20454291 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20235076 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19322474 |
| 90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17520200 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17385621 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17253792 |
| 93 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16552138 |
| 94 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.16217204 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15898097 |
| 96 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13521519 |
| 97 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13425289 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13364429 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.12479180 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11938100 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11618277 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.11030416 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10981405 |
| 104 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10137855 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09693046 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08826932 |
| 107 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08335959 |
| 108 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.06713131 |
| 109 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.05777616 |
| 110 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.05242728 |
| 111 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05198757 |
| 112 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05194087 |
| 113 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05097791 |
| 114 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03778366 |
| 115 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03715287 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03439096 |
| 117 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03047360 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.03014539 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01569794 |
| 120 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01553616 |
| 121 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01433533 |
| 122 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01323437 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01046732 |
| 124 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00552258 |
| 125 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99070757 |
| 126 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98773494 |
| 127 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.97453626 |
| 128 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96962529 |
| 129 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96874936 |
| 130 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95732441 |
| 131 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94839845 |
| 132 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.91901822 |
| 133 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.91294981 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91229144 |
| 135 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90200972 |
| 136 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.89666946 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89322237 |
| 138 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88627444 |
| 139 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87687164 |
| 140 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.87459738 |
| 141 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87105180 |
| 142 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85904380 |
| 143 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.82217646 |
| 144 | P68_20966046_ChIP-Seq_HELA_Human | 0.81687651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.58006179 |
| 2 | MP0008260_abnormal_autophagy | 3.09201726 |
| 3 | MP0005451_abnormal_body_composition | 2.80173382 |
| 4 | MP0008057_abnormal_DNA_replication | 2.67444827 |
| 5 | MP0001800_abnormal_humoral_immune | 2.59545198 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.55427669 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.51111069 |
| 8 | MP0002452_abnormal_antigen_presenting | 2.26921140 |
| 9 | MP0009278_abnormal_bone_marrow | 2.23637983 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.20278697 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.18185412 |
| 12 | MP0005671_abnormal_response_to | 2.18155926 |
| 13 | MP0001790_abnormal_immune_system | 2.14887506 |
| 14 | MP0005387_immune_system_phenotype | 2.14887506 |
| 15 | MP0003724_increased_susceptibility_to | 2.12788014 |
| 16 | MP0002398_abnormal_bone_marrow | 2.12686567 |
| 17 | MP0005174_abnormal_tail_pigmentation | 2.11384065 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.08573256 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.08221296 |
| 20 | MP0005000_abnormal_immune_tolerance | 2.08148443 |
| 21 | MP0001819_abnormal_immune_cell | 2.03554053 |
| 22 | MP0003303_peritoneal_inflammation | 1.98690196 |
| 23 | MP0002723_abnormal_immune_serum | 1.98009327 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.96402643 |
| 25 | MP0000685_abnormal_immune_system | 1.92363339 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.91099434 |
| 27 | MP0003283_abnormal_digestive_organ | 1.88761713 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.85965108 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.84815592 |
| 30 | MP0000716_abnormal_immune_system | 1.83810404 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.83243242 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.82197850 |
| 33 | MP0004858_abnormal_nervous_system | 1.76076746 |
| 34 | MP0009840_abnormal_foam_cell | 1.73696628 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.71875588 |
| 36 | MP0002722_abnormal_immune_system | 1.68938089 |
| 37 | MP0000703_abnormal_thymus_morphology | 1.68651690 |
| 38 | MP0000858_altered_metastatic_potential | 1.67903522 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.64631926 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.62507224 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.60194861 |
| 42 | MP0003077_abnormal_cell_cycle | 1.60116207 |
| 43 | MP0002429_abnormal_blood_cell | 1.59846676 |
| 44 | MP0002419_abnormal_innate_immunity | 1.56854301 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.55195144 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.54189719 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.53435303 |
| 48 | MP0003828_pulmonary_edema | 1.52516077 |
| 49 | MP0002405_respiratory_system_inflammati | 1.50638474 |
| 50 | MP0003122_maternal_imprinting | 1.50279230 |
| 51 | MP0003075_altered_response_to | 1.49371905 |
| 52 | MP0003121_genomic_imprinting | 1.46948087 |
| 53 | MP0003436_decreased_susceptibility_to | 1.46652873 |
| 54 | MP0005076_abnormal_cell_differentiation | 1.46130741 |
| 55 | MP0001849_ear_inflammation | 1.45261067 |
| 56 | MP0008877_abnormal_DNA_methylation | 1.42433134 |
| 57 | MP0005025_abnormal_response_to | 1.39757547 |
| 58 | MP0008058_abnormal_DNA_repair | 1.37128526 |
| 59 | MP0010307_abnormal_tumor_latency | 1.34227493 |
| 60 | MP0004947_skin_inflammation | 1.33789293 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 1.29323202 |
| 62 | MP0008995_early_reproductive_senescence | 1.27221019 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.26309609 |
| 64 | MP0003890_abnormal_embryonic-extraembry | 1.25592422 |
| 65 | MP0003787_abnormal_imprinting | 1.18413978 |
| 66 | MP0004510_myositis | 1.18136221 |
| 67 | MP0003693_abnormal_embryo_hatching | 1.17497983 |
| 68 | MP0002653_abnormal_ependyma_morphology | 1.16176685 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.15119152 |
| 70 | MP0008469_abnormal_protein_level | 1.14855564 |
| 71 | MP0001851_eye_inflammation | 1.14751196 |
| 72 | MP0000350_abnormal_cell_proliferation | 1.14714364 |
| 73 | MP0005377_hearing/vestibular/ear_phenot | 1.12897870 |
| 74 | MP0003878_abnormal_ear_physiology | 1.12897870 |
| 75 | MP0005310_abnormal_salivary_gland | 1.11374763 |
| 76 | MP0004381_abnormal_hair_follicle | 1.08615854 |
| 77 | MP0002933_joint_inflammation | 1.08386789 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.06236249 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.06236249 |
| 80 | MP0001730_embryonic_growth_arrest | 1.05863225 |
| 81 | MP0001293_anophthalmia | 1.04912563 |
| 82 | MP0000604_amyloidosis | 1.03872718 |
| 83 | MP0000371_diluted_coat_color | 1.03787296 |
| 84 | MP0008004_abnormal_stomach_pH | 1.03371761 |
| 85 | MP0002148_abnormal_hypersensitivity_rea | 1.02753137 |
| 86 | MP0001853_heart_inflammation | 1.02675948 |
| 87 | MP0004957_abnormal_blastocyst_morpholog | 1.02484941 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 1.01466559 |
| 89 | MP0000678_abnormal_parathyroid_gland | 1.01316810 |
| 90 | MP0004185_abnormal_adipocyte_glucose | 1.00663284 |
| 91 | MP0003329_amyloid_beta_deposits | 1.00606286 |
| 92 | MP0000343_altered_response_to | 1.00531537 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.96518654 |
| 94 | MP0009764_decreased_sensitivity_to | 0.96234328 |
| 95 | MP0001873_stomach_inflammation | 0.96059084 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.95030339 |
| 97 | MP0005390_skeleton_phenotype | 0.93815916 |
| 98 | MP0005409_darkened_coat_color | 0.93086726 |
| 99 | MP0003690_abnormal_glial_cell | 0.92433290 |
| 100 | MP0003866_abnormal_defecation | 0.87117241 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.86938846 |
| 102 | MP0004133_heterotaxia | 0.85632460 |
| 103 | MP0000313_abnormal_cell_death | 0.84879112 |
| 104 | MP0005166_decreased_susceptibility_to | 0.84869296 |
| 105 | MP0006082_CNS_inflammation | 0.84761554 |
| 106 | MP0008007_abnormal_cellular_replicative | 0.84562832 |
| 107 | MP0003795_abnormal_bone_structure | 0.84295396 |
| 108 | MP0002019_abnormal_tumor_incidence | 0.84214963 |
| 109 | MP0002092_abnormal_eye_morphology | 0.82246756 |
| 110 | MP0000733_abnormal_muscle_development | 0.82169411 |
| 111 | MP0002084_abnormal_developmental_patter | 0.81640814 |
| 112 | MP0001529_abnormal_vocalization | 0.80718785 |
| 113 | MP0003566_abnormal_cell_adhesion | 0.79978883 |
| 114 | MP0005621_abnormal_cell_physiology | 0.78651819 |
| 115 | MP0001845_abnormal_inflammatory_respons | 0.77435972 |
| 116 | MP0004742_abnormal_vestibular_system | 0.77238457 |
| 117 | MP0004264_abnormal_extraembryonic_tissu | 0.77040257 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.76788032 |
| 119 | MP0002085_abnormal_embryonic_tissue | 0.76588901 |
| 120 | MP0001663_abnormal_digestive_system | 0.76575934 |
| 121 | MP0002080_prenatal_lethality | 0.75748889 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.73885908 |
| 123 | MP0005645_abnormal_hypothalamus_physiol | 0.73719038 |
| 124 | MP0001958_emphysema | 0.73130824 |
| 125 | MP0002132_abnormal_respiratory_system | 0.72937082 |
| 126 | MP0002075_abnormal_coat/hair_pigmentati | 0.72103147 |
| 127 | MP0003448_altered_tumor_morphology | 0.71921546 |
| 128 | MP0004197_abnormal_fetal_growth/weight/ | 0.70599436 |
| 129 | MP0003656_abnormal_erythrocyte_physiolo | 0.70168488 |
| 130 | MP0000383_abnormal_hair_follicle | 0.69929621 |
| 131 | MP0003279_aneurysm | 0.69371437 |
| 132 | MP0000490_abnormal_crypts_of | 0.69075474 |
| 133 | MP0002102_abnormal_ear_morphology | 0.68839133 |
| 134 | MP0002796_impaired_skin_barrier | 0.68608391 |
| 135 | MP0000920_abnormal_myelination | 0.68317007 |
| 136 | MP0008874_decreased_physiological_sensi | 0.67014107 |
| 137 | MP0001727_abnormal_embryo_implantation | 0.66537567 |
| 138 | MP0002166_altered_tumor_susceptibility | 0.65268337 |
| 139 | MP0003091_abnormal_cell_migration | 0.64901323 |
| 140 | MP0002877_abnormal_melanocyte_morpholog | 0.64355642 |
| 141 | MP0009785_altered_susceptibility_to | 0.63413396 |
| 142 | MP0001915_intracranial_hemorrhage | 0.61873263 |
| 143 | MP0004883_abnormal_blood_vessel | 0.61457754 |
| 144 | MP0009931_abnormal_skin_appearance | 0.60736762 |
| 145 | MP0003634_abnormal_glial_cell | 0.59365374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Agammaglobulinemia (HP:0004432) | 4.06968441 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.60443698 |
| 3 | Cellulitis (HP:0100658) | 3.45073757 |
| 4 | IgM deficiency (HP:0002850) | 3.43825400 |
| 5 | Myositis (HP:0100614) | 3.37733373 |
| 6 | Nasal polyposis (HP:0100582) | 3.36265486 |
| 7 | Colitis (HP:0002583) | 3.20936475 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.13971081 |
| 9 | Recurrent bronchitis (HP:0002837) | 3.13728670 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 3.13652609 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.13384037 |
| 12 | Recurrent viral infections (HP:0004429) | 3.09447271 |
| 13 | Abnormality of the nasal mucosa (HP:0000433) | 3.08819372 |
| 14 | Inflammation of the large intestine (HP:0002037) | 3.08601519 |
| 15 | Dysostosis multiplex (HP:0000943) | 3.03997575 |
| 16 | Panhypogammaglobulinemia (HP:0003139) | 2.97025111 |
| 17 | Gastrointestinal stroma tumor (HP:0100723) | 2.95280866 |
| 18 | Increased IgE level (HP:0003212) | 2.90386112 |
| 19 | Abnormal number of incisors (HP:0011064) | 2.90096531 |
| 20 | Abnormality of the fingertips (HP:0001211) | 2.85454834 |
| 21 | Chronic otitis media (HP:0000389) | 2.81623508 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77386008 |
| 23 | Recurrent fungal infections (HP:0002841) | 2.72987993 |
| 24 | Increased cerebral lipofuscin (HP:0011813) | 2.67881069 |
| 25 | Gingivitis (HP:0000230) | 2.62665972 |
| 26 | Orchitis (HP:0100796) | 2.59692398 |
| 27 | Emphysema (HP:0002097) | 2.59528773 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59364945 |
| 29 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59364945 |
| 30 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59364945 |
| 31 | Amyloidosis (HP:0011034) | 2.54674397 |
| 32 | Hyperacusis (HP:0010780) | 2.52170169 |
| 33 | Thyroiditis (HP:0100646) | 2.46710492 |
| 34 | Lymphopenia (HP:0001888) | 2.44408336 |
| 35 | Metaphyseal cupping (HP:0003021) | 2.42317361 |
| 36 | Osteomyelitis (HP:0002754) | 2.38528708 |
| 37 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36717145 |
| 38 | Thoracic kyphosis (HP:0002942) | 2.36635402 |
| 39 | Ependymoma (HP:0002888) | 2.36450360 |
| 40 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.35198819 |
| 41 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.33482065 |
| 42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.33482065 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.33482065 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.33087012 |
| 45 | Polygenic inheritance (HP:0010982) | 2.31909323 |
| 46 | Recurrent sinusitis (HP:0011108) | 2.29735738 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.29034116 |
| 48 | Purpura (HP:0000979) | 2.27625474 |
| 49 | Mucopolysacchariduria (HP:0008155) | 2.27343396 |
| 50 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.27343396 |
| 51 | Meningitis (HP:0001287) | 2.27255558 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.26679734 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.26679734 |
| 54 | Obstructive sleep apnea (HP:0002870) | 2.25440663 |
| 55 | Abnormality of the thoracic spine (HP:0100711) | 2.23289296 |
| 56 | Broad face (HP:0000283) | 2.22973069 |
| 57 | Tented upper lip vermilion (HP:0010804) | 2.21702945 |
| 58 | Urticaria (HP:0001025) | 2.20994748 |
| 59 | Restrictive lung disease (HP:0002091) | 2.20692967 |
| 60 | Agnosia (HP:0010524) | 2.20254801 |
| 61 | Absent frontal sinuses (HP:0002688) | 2.19777111 |
| 62 | Eczematoid dermatitis (HP:0000976) | 2.19528956 |
| 63 | Vertebral arch anomaly (HP:0008438) | 2.18619030 |
| 64 | Mediastinal lymphadenopathy (HP:0100721) | 2.17431196 |
| 65 | Abnormality of macrophages (HP:0004311) | 2.17240163 |
| 66 | Heterotopia (HP:0002282) | 2.16928392 |
| 67 | Thin bony cortex (HP:0002753) | 2.15244970 |
| 68 | Recurrent skin infections (HP:0001581) | 2.13879282 |
| 69 | Upper limb amyotrophy (HP:0009129) | 2.13753694 |
| 70 | Distal upper limb amyotrophy (HP:0007149) | 2.13753694 |
| 71 | J-shaped sella turcica (HP:0002680) | 2.13245006 |
| 72 | Flat acetabular roof (HP:0003180) | 2.12117466 |
| 73 | Verrucae (HP:0200043) | 2.11854944 |
| 74 | Papilloma (HP:0012740) | 2.11854944 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.11558618 |
| 76 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.10281807 |
| 77 | Pustule (HP:0200039) | 2.07932556 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.07549340 |
| 79 | Optic neuritis (HP:0100653) | 2.07549340 |
| 80 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.06110417 |
| 81 | Long eyelashes (HP:0000527) | 2.03277466 |
| 82 | Upper motor neuron abnormality (HP:0002127) | 2.03156598 |
| 83 | Nuclear cataract (HP:0100018) | 2.02731841 |
| 84 | Chronic sinusitis (HP:0011109) | 2.01895317 |
| 85 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.01527802 |
| 86 | Prolonged bleeding time (HP:0003010) | 2.01153330 |
| 87 | Loss of speech (HP:0002371) | 1.98271861 |
| 88 | Prominent nose (HP:0000448) | 1.98260876 |
| 89 | T lymphocytopenia (HP:0005403) | 1.98099705 |
| 90 | Lymphoma (HP:0002665) | 1.97507502 |
| 91 | Chronic obstructive pulmonary disease (HP:0006510) | 1.97341966 |
| 92 | Obstructive lung disease (HP:0006536) | 1.97341966 |
| 93 | Renal duplication (HP:0000075) | 1.97121083 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 1.96852305 |
| 95 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.96516875 |
| 96 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.96516875 |
| 97 | Overriding aorta (HP:0002623) | 1.96363058 |
| 98 | Hand muscle atrophy (HP:0009130) | 1.95791802 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.95331738 |
| 100 | Increased serum ferritin (HP:0003281) | 1.94447164 |
| 101 | Bronchitis (HP:0012387) | 1.92197925 |
| 102 | Recurrent pneumonia (HP:0006532) | 1.90921538 |
| 103 | Pathologic fracture (HP:0002756) | 1.90462864 |
| 104 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90147860 |
| 105 | Axonal loss (HP:0003447) | 1.87507081 |
| 106 | Leukopenia (HP:0001882) | 1.87431996 |
| 107 | Episodic fever (HP:0001954) | 1.86937248 |
| 108 | Systemic lupus erythematosus (HP:0002725) | 1.86666793 |
| 109 | Vasculitis (HP:0002633) | 1.86242644 |
| 110 | Thrombocytosis (HP:0001894) | 1.85686586 |
| 111 | Failure to thrive in infancy (HP:0001531) | 1.84545515 |
| 112 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.84324332 |
| 113 | Absent/shortened dynein arms (HP:0200106) | 1.84324332 |
| 114 | Vertebral compression fractures (HP:0002953) | 1.84178451 |
| 115 | Small epiphyses (HP:0010585) | 1.84008442 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 1.81895666 |
| 117 | Petechiae (HP:0000967) | 1.81756472 |
| 118 | Neuronal loss in central nervous system (HP:0002529) | 1.80853258 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.80384254 |
| 120 | Spontaneous hematomas (HP:0007420) | 1.80111274 |
| 121 | Abnormal ciliary motility (HP:0012262) | 1.80045166 |
| 122 | Sepsis (HP:0100806) | 1.79695414 |
| 123 | Apathy (HP:0000741) | 1.79540531 |
| 124 | Atelectasis (HP:0100750) | 1.78803685 |
| 125 | Epistaxis (HP:0000421) | 1.78276899 |
| 126 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78098611 |
| 127 | Recurrent otitis media (HP:0000403) | 1.77495222 |
| 128 | Mitral regurgitation (HP:0001653) | 1.76869313 |
| 129 | Long palpebral fissure (HP:0000637) | 1.75778763 |
| 130 | Cervical subluxation (HP:0003308) | 1.75319140 |
| 131 | Abnormality of T cells (HP:0002843) | 1.74790503 |
| 132 | Hypergammaglobulinemia (HP:0010702) | 1.74283534 |
| 133 | Personality changes (HP:0000751) | 1.74268146 |
| 134 | IgG deficiency (HP:0004315) | 1.74261106 |
| 135 | Recurrent lower respiratory tract infections (HP:0002783) | 1.74060162 |
| 136 | Premature loss of primary teeth (HP:0006323) | 1.73577610 |
| 137 | Abnormality of the peritoneum (HP:0002585) | 1.73476178 |
| 138 | Abnormality of T cell number (HP:0011839) | 1.73058085 |
| 139 | Diminished motivation (HP:0000745) | 1.71957737 |
| 140 | B lymphocytopenia (HP:0010976) | 1.70545448 |
| 141 | Abnormality of B cell number (HP:0010975) | 1.70545448 |
| 142 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.70019242 |
| 143 | Anteriorly placed anus (HP:0001545) | 1.69005091 |
| 144 | Limited elbow extension (HP:0001377) | 1.68827134 |
| 145 | Ulnar bowing (HP:0003031) | 1.67801705 |
| 146 | Severe combined immunodeficiency (HP:0004430) | 1.67520903 |
| 147 | Disinhibition (HP:0000734) | 1.67358451 |
| 148 | Poikiloderma (HP:0001029) | 1.66947187 |
| 149 | Abnormality of the right ventricle (HP:0001707) | 1.66285280 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.66205700 |
| 151 | Stomatitis (HP:0010280) | 1.65928945 |
| 152 | Spondylolisthesis (HP:0003302) | 1.65220938 |
| 153 | Intestinal fistula (HP:0100819) | 1.64679352 |
| 154 | Trigonocephaly (HP:0000243) | 1.64603823 |
| 155 | Insomnia (HP:0100785) | 1.64255196 |
| 156 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.63740955 |
| 157 | Increased nuchal translucency (HP:0010880) | 1.63015744 |
| 158 | Volvulus (HP:0002580) | 1.61615682 |
| 159 | Neoplasm of the oral cavity (HP:0100649) | 1.61228191 |
| 160 | Cerebral aneurysm (HP:0004944) | 1.61164138 |
| 161 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.60586178 |
| 162 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.60586178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BRD4 | 4.85648557 |
| 2 | MAP4K1 | 4.43575171 |
| 3 | PRPF4B | 3.37940257 |
| 4 | CDK12 | 3.29024453 |
| 5 | EEF2K | 2.81802449 |
| 6 | MAP3K10 | 2.76009178 |
| 7 | SMG1 | 2.74756048 |
| 8 | SIK1 | 2.51807038 |
| 9 | RIPK4 | 2.46983132 |
| 10 | BLK | 2.40340261 |
| 11 | SIK3 | 2.35303771 |
| 12 | SIK2 | 2.33376236 |
| 13 | PASK | 2.31231792 |
| 14 | IRAK3 | 2.00028345 |
| 15 | CSF1R | 1.96145621 |
| 16 | CLK1 | 1.95507807 |
| 17 | KIT | 1.84726692 |
| 18 | BTK | 1.79101894 |
| 19 | NEK2 | 1.66134971 |
| 20 | GRK6 | 1.66027881 |
| 21 | STK10 | 1.65932321 |
| 22 | ICK | 1.65924758 |
| 23 | NME2 | 1.64243996 |
| 24 | ITK | 1.62278945 |
| 25 | MAP3K13 | 1.61519229 |
| 26 | SYK | 1.59708557 |
| 27 | ERN1 | 1.59139048 |
| 28 | MAP3K3 | 1.49490589 |
| 29 | RIPK1 | 1.44553882 |
| 30 | TAOK2 | 1.41231932 |
| 31 | UHMK1 | 1.29742170 |
| 32 | ALK | 1.26749137 |
| 33 | HCK | 1.26042767 |
| 34 | TRIB3 | 1.25998022 |
| 35 | IRAK4 | 1.25545389 |
| 36 | ZAP70 | 1.20915714 |
| 37 | EPHB1 | 1.18234043 |
| 38 | PRKD2 | 1.07740767 |
| 39 | LCK | 1.07522980 |
| 40 | CAMK1G | 1.07140175 |
| 41 | MAP3K6 | 1.06208464 |
| 42 | LRRK2 | 1.06139607 |
| 43 | TBK1 | 1.03275086 |
| 44 | FES | 1.03164463 |
| 45 | CDC42BPA | 1.02727033 |
| 46 | TYK2 | 1.01407350 |
| 47 | MAP3K9 | 1.00552648 |
| 48 | MAP3K1 | 0.98886549 |
| 49 | KSR1 | 0.96748935 |
| 50 | PDPK1 | 0.96509247 |
| 51 | LYN | 0.92663068 |
| 52 | KSR2 | 0.90828149 |
| 53 | CSK | 0.89515859 |
| 54 | PAK4 | 0.88746076 |
| 55 | MARK2 | 0.87562245 |
| 56 | CAMK1D | 0.86796901 |
| 57 | MAPK12 | 0.86768811 |
| 58 | TYRO3 | 0.86574794 |
| 59 | MAP3K11 | 0.86509542 |
| 60 | TESK2 | 0.86270706 |
| 61 | ATR | 0.83460765 |
| 62 | MARK3 | 0.83267029 |
| 63 | MATK | 0.79517868 |
| 64 | NEK1 | 0.79478261 |
| 65 | HIPK2 | 0.78579467 |
| 66 | EPHA2 | 0.75270310 |
| 67 | FLT3 | 0.73649313 |
| 68 | PIM1 | 0.72550379 |
| 69 | PDK1 | 0.71958167 |
| 70 | BUB1 | 0.70959116 |
| 71 | CDC7 | 0.69363796 |
| 72 | CAMKK1 | 0.69028666 |
| 73 | CHEK1 | 0.68386478 |
| 74 | PKN2 | 0.68317338 |
| 75 | DYRK3 | 0.67980863 |
| 76 | IRAK2 | 0.67395206 |
| 77 | DYRK1B | 0.67380242 |
| 78 | ARAF | 0.65558569 |
| 79 | MAP3K7 | 0.65469972 |
| 80 | MAP3K14 | 0.65451220 |
| 81 | MAP2K2 | 0.65087177 |
| 82 | CDK7 | 0.64563198 |
| 83 | PIM2 | 0.64523149 |
| 84 | MTOR | 0.64494895 |
| 85 | WEE1 | 0.64117180 |
| 86 | TLK1 | 0.63452538 |
| 87 | TESK1 | 0.62735944 |
| 88 | IKBKB | 0.62288735 |
| 89 | MAPK11 | 0.62186502 |
| 90 | TSSK6 | 0.61488996 |
| 91 | YES1 | 0.61050466 |
| 92 | PTK6 | 0.60499055 |
| 93 | CDK9 | 0.60254113 |
| 94 | FYN | 0.58772800 |
| 95 | STK4 | 0.58544177 |
| 96 | JAK2 | 0.57428753 |
| 97 | CHUK | 0.57034378 |
| 98 | RPS6KB2 | 0.56967129 |
| 99 | RET | 0.56914329 |
| 100 | IKBKE | 0.55422420 |
| 101 | FGFR2 | 0.55076967 |
| 102 | PRKCH | 0.54315815 |
| 103 | TEC | 0.54203395 |
| 104 | PDGFRB | 0.53930208 |
| 105 | BMX | 0.53609732 |
| 106 | FGFR3 | 0.51992525 |
| 107 | MAP2K3 | 0.51361597 |
| 108 | TTN | 0.51351809 |
| 109 | RPS6KA2 | 0.51276031 |
| 110 | PRKD3 | 0.50947496 |
| 111 | MAPK7 | 0.50666075 |
| 112 | FGR | 0.49837802 |
| 113 | TGFBR2 | 0.49470996 |
| 114 | STK11 | 0.47593685 |
| 115 | CDK19 | 0.47492022 |
| 116 | PAK2 | 0.47475791 |
| 117 | LMTK2 | 0.43447838 |
| 118 | TAOK1 | 0.42905599 |
| 119 | MOS | 0.42904866 |
| 120 | TNK2 | 0.42406679 |
| 121 | JAK1 | 0.42273509 |
| 122 | MELK | 0.42122937 |
| 123 | BRAF | 0.42031495 |
| 124 | AKT2 | 0.41940937 |
| 125 | STK38 | 0.40872838 |
| 126 | PDGFRA | 0.39171606 |
| 127 | JAK3 | 0.38982178 |
| 128 | RPS6KA6 | 0.38939319 |
| 129 | CDK2 | 0.38869293 |
| 130 | MAP2K6 | 0.38839900 |
| 131 | DDR2 | 0.38775671 |
| 132 | CSNK1D | 0.35915437 |
| 133 | RPS6KC1 | 0.35815993 |
| 134 | RPS6KL1 | 0.35815993 |
| 135 | MAP3K8 | 0.35146801 |
| 136 | CDK4 | 0.32406589 |
| 137 | MAPK15 | 0.32225004 |
| 138 | PAK6 | 0.31761274 |
| 139 | MAPK10 | 0.31181008 |
| 140 | FGFR4 | 0.30778776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.70725185 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.57107919 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45389310 |
| 4 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.03051119 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 1.85627626 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 1.85626766 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 1.84570127 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79138745 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.61544978 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.61245905 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61041503 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60488115 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 1.54790477 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49157139 |
| 15 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.48005599 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46619810 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46541408 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.44175077 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.42690790 |
| 20 | Allograft rejection_Homo sapiens_hsa05330 | 1.40030143 |
| 21 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.35585891 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34753562 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33977936 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.32950913 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30113210 |
| 26 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.29904828 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.27361846 |
| 28 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.20382900 |
| 29 | Cell cycle_Homo sapiens_hsa04110 | 1.16057266 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.14917670 |
| 31 | Measles_Homo sapiens_hsa05162 | 1.13607557 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.13125281 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13062089 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.12871296 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12210599 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08246980 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.07268774 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06647010 |
| 39 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04706066 |
| 40 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.02486252 |
| 41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02129484 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01198338 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.00922751 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00423823 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.99131376 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96980994 |
| 47 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.96805300 |
| 48 | Colorectal cancer_Homo sapiens_hsa05210 | 0.95269211 |
| 49 | HTLV-I infection_Homo sapiens_hsa05166 | 0.94519308 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93456932 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 0.93357227 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.93179258 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.91977468 |
| 54 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.90919164 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.90633548 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.90381474 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89949546 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.88671543 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.88380170 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87993319 |
| 61 | Viral myocarditis_Homo sapiens_hsa05416 | 0.87668703 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.87564954 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.87407007 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.86495623 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85666817 |
| 66 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85595709 |
| 67 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85414590 |
| 68 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84689371 |
| 69 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.84083872 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83765737 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83151904 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82612033 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82233769 |
| 74 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.81621336 |
| 75 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81528863 |
| 76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79527871 |
| 77 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.77264626 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76659422 |
| 79 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.76627118 |
| 80 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.76128080 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.75434814 |
| 82 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75100090 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.73723423 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72453734 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72393453 |
| 86 | Pertussis_Homo sapiens_hsa05133 | 0.72083348 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.71198279 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.70273580 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69639172 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.68898160 |
| 91 | Glioma_Homo sapiens_hsa05214 | 0.68585113 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.67638110 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67119068 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66574730 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66447366 |
| 96 | Salmonella infection_Homo sapiens_hsa05132 | 0.66087328 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65056206 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64462710 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62811956 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62359881 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62304306 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62011504 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.61900158 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61855871 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60955744 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60884845 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.59647705 |
| 108 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59589657 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.59205107 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57801555 |
| 111 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.57472372 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.57233838 |
| 113 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56846606 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.56836097 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55814878 |
| 116 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55608130 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54893752 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54777926 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53347826 |
| 120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53193449 |
| 121 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52659664 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51989061 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51927222 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50871883 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.50540643 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.50329448 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.49512536 |
| 128 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49502099 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.48050782 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44783726 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.44710655 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44446347 |

